All News

Clinical trials lead to new cancer treatments — and can give a patient access to effective drugs years before they’re made available to the public.

You know yourself best, so try and figure out what works best for you and do not be afraid to give yourself the precious gift of self-care during and after your cancer journey. You deserve this.

In this week’s episode of the CURE® Talks Cancer podcast, we chat with Dr. Tanja Gruber, the chief of pediatric hematology, oncology and stem cell transplantation at Stanford Children’s Health, about how pediatric cancer treatment is evolving thanks to advances in treatments like immunotherapy, and what parents should do after their child receives a diagnosis.

Here is a list of some recent trials that launched within the cancer space in September.

There is no approved treatment that targets the KRAS p.G12C mutation that drives some cancers like non-small cell lung cancer. But a recent study shows how the experimental drug sotorasib sparked responses in some patients with advanced non-small cell lung cancer that harbored the mutation.

For years, childhood blood cancers were understudied forcing patients’ treatments into a one size-fits-all approach. But new efforts are changing that.

I suffered a recurrence a few years ago and couldn’t bear to hear, or utter, the word “cancer.” So, I decided to counter-attack by belittling the disease and calling it “chocolate.” Then, I got my sweet revenge.

Weighing the cost of CAR-T cell therapy in treating blood cancers is a finical burden for many patients with blood cancer.

The PARP inhibitor Lynparza reduced the risk for death by 31% in men with metastatic castration-resistant prostate cancer compared with Xtandi or Zytiga plus the corticosteroid prednisone.

Findings from a randomized phase 3 study showed that adding neoadjuvant Tecentriq to a chemotherapy regimen of Abraxane, Adriamycin and Cytoxan in patients with stage 2 or 3 triple-negative breast cancer significantly improved pathologic complete responses, compared with placebo plus chemotherapy.

Exciting advances in treatment options for patients with mantle cell lymphoma are greatly improving the outlook for long-term remissions.

There are some amazing studies that show how certain birds help each other in times of need. For us cancer survivors, we should be like these birds and help each other more.

CAR-T Cell therapy is expanding in the field of blood cancers, but it comes with a host of side effects patients need to look out for. One study is looking to get ahead of the side effect curve for patients about to undergo CAR-T cell therapy.

In the winning essay for the Finest Hour award, Evangelina SantaTeresa, CCRN, details how the human touch makes all the difference for award winner Elizabeth “Liz” Farrat, B.S.N., CCRN at Memorial Sloan Kettering Cancer Center.

Save the date! We invite you to join CURE for our next monthly #CureConnect Tweet Chat on Thursday, September 24, at 1 p.m. EST, when we plan on discussing living with cancer, from mental health through treatment, to cancer-related pain and beyond.

On social media, CURE® recently asked its readers to share how they deal with the cognitive dysfunction that can come about from cancer treatment.

The greatest obstacle facing men with breast cancer may be … ourselves.

An oncology nurse outlines ways that patients can prevent dental erosion after a vomiting episode.

You have a new cancer diagnosis that stops you in your tracks. You are sick, afraid, vulnerable and in pain when you come to the cancer center at Temple University Hospital. The first advocate you will meet on your cancer journey is your nurse navigator

In a finalist essay, Laurie Loe details why Vicki Dodson, B.S.N., RN, OCN, is an extraordinary healer and a great mentor.

As difficult as my cancer journey was, there were a lot of good things that came out of it. Cancer changed my life. It changed my perspective. It showed me what is truly important and valuable in life.

Some cancers and treatments can result in cognitive changes that affect thinking, learning, processing or remembering information. These changes can affect many aspects of life such as the ability to work or even to do everyday tasks. Find out whether you have an increased risk of cognitive changes.

Each person responds to treatment differently. No one knows in advance how effective cancer treatment will be. There's also no way to know how long anyone will live—with or without cancer.

Lynne O’Connor’s winning essay describes how Christine Santure, B.S.N., RN, OCN, is this year’s Extraordinary Healer winner by caring for the caregiver.

Supreme Court Justice Ruth Bader Ginsburg died after five bouts with cancer.

I’ve already warned my family, if I decide to act a little crazy in the future, don’t worry. I’ve got a good excuse. I can always blame it on the cancer. It’s a good excuse, sometimes.

One to three percent of survivors develop a second cancer different from the originally treated cancer. The level of risk is small, and greater numbers of survivors are living longer due to improvements in treatment. However, even thinking about the possibility of having a second cancer can be stressful.

From new research finding an association with longer survival in patients with colorectal cancer and the amount of coffee they drink in a day to the historic wildfires in northern California damaging, and possibly destroying, a summer camp for pediatric patients with cancer and more, here’s what’s happening in the cancer landscape this week.

At a virtual event Sept. 17, CURE® also named Elizabeth Farrat, B.S.N., RN, CCRN-K, the winner of its first-ever Finest Hour Award for selfless achievements in care during the COVID-19 pandemic.

“This randomized clinical trial found that compared with the conventional anthracycline and docetaxel regimen, the paclitaxel-plus-carboplatin regimen may be an alternative adjuvant chemotherapy strategy for patients with operable TNBC,” the authors wrote.